Page last updated: 2024-08-26

nicotine and Dyskinesia, Drug-Induced

nicotine has been researched along with Dyskinesia, Drug-Induced in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (11.54)	18.7374
1990's	4 (15.38)	18.2507
2000's	2 (7.69)	29.6817
2010's	17 (65.38)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koski, SK; Leino, S; Rannanpää, S; Salminen, O	1
Drucker-Colín, R; Enríquez-Traba, J; García-Montes, JR; Moratalla, R; Ruiz-DeDiego, I; Solís, O	1
Kohtala, S; Koski, SK; Leino, S; Rannanpää, S; Rantamäki, T; Salminen, O	1
Ly, J; Mallela, A; Quik, M; Zhang, D	1
Bencherif, M; Carroll, FI; Letchworth, S; Mallela, A; Quik, M; Sohn, D; Zhang, D	1
Gan, J; Liu, ZG; Pan, JL; Xie, CL; Zhang, SF	1
Bordia, T; Perez, XA; Quik, M; Zhang, D	1
Bordia, T; Drenan, RM; McGregor, M; McIntosh, JM; Quik, M	1
Bordia, T; Heiss, J; Perez, XA; Quik, M; Zhang, D	1
Guo, A; Guo, J; Li, Y; Zhang, Y	1
Bordia, T; Campos, C; Huang, L; Quik, M	1
Bordia, T; Campos, C; McIntosh, JM; Quik, M	1
Grady, SR; Huang, LZ; Quik, M	1
Bevins, RA; Dion, AM; Murrin, LC; Sanderson, SC	1
Bordia, T; McIntosh, JM; Quik, M	2
Grady, SR; Hrachova, M; Huang, LZ; Mallela, A; McIntosh, JM; Park, KM; Quik, M	1
Bordia, T; Chin, M; Mallela, A; McIntosh, JM; Perez, XA; Quik, M	1
Cox, H; Di Monte, D; Langston, JW; O'Leary, K; Parameswaran, N; Quik, M	1
Erdmann, R	2
Flynn, K; Lohr, JB	1
Kirch, DG	1
Ikegami, H; Prasad, C; Spahn, SA	1
Alho, AM; Kirch, DG; Wyatt, RJ	1
Ally, J; Korpassy, A; Lal, S; Yassa, R	1

Reviews

6 review(s) available for nicotine and Dyskinesia, Drug-Induced

Article	Year
Effect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:5 Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Ganglionic Stimulants; Levodopa; Nicotine; Parkinsonian Disorders	2014
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. Pharmacology & therapeutics, 2014, Volume: 144, Issue:1 Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Drug Design; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Nicotine; Nicotinic Agonists; Receptors, Nicotinic	2014
[Neuroleptics and nicotine]. Psychiatrische Praxis, 1995, Volume: 22, Issue:6 Topics: Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Humans; Nicotine; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, GABA; Receptors, Glutamate; Schizophrenia; Schizophrenic Psychology; Smoking	1995
[Nicotine in neuropsychiatric movement disorders]. Fortschritte der Neurologie-Psychiatrie, 1996, Volume: 64, Issue:9 Topics: Adult; Akathisia, Drug-Induced; Brain; Child; Dyskinesia, Drug-Induced; Haloperidol; Humans; Nicotine; Parkinson Disease; Receptors, Dopamine; Tourette Syndrome	1996
Smoking and schizophrenia. Schizophrenia research, 1992, Volume: 8, Issue:2 Topics: Antipsychotic Agents; Dopamine; Dyskinesia, Drug-Induced; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Smoking	1992
Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia. Cellular and molecular neurobiology, 1988, Volume: 8, Issue:3 Topics: Dopamine; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Nicotine; Parkinson Disease, Secondary; Smoking	1988

Other Studies

20 other study(ies) available for nicotine and Dyskinesia, Drug-Induced

Article	Year
Effects of antidyskinetic nicotine treatment on dopamine release in dorsal and ventral striatum. Neuroscience letters, 2018, 04-13, Volume: 672 Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Mice; Nicotine; Nicotinic Agonists; Synaptosomes	2018
Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice. Molecular neurobiology, 2019, Volume: 56, Issue:6 Topics: Allosteric Regulation; Animals; Aphakia; Biomarkers; Corpus Striatum; Down-Regulation; Dyskinesia, Drug-Induced; Female; Gene Knockdown Techniques; Levodopa; Male; Mice, Inbred C57BL; Models, Biological; Neurons; Nicotine; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D1	2019
Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation. BMC neuroscience, 2018, Nov-29, Volume: 19, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Brain-Derived Neurotrophic Factor; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Furans; Levodopa; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Quinuclidines; Random Allocation	2018
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:10 Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Cotinine; Data Interpretation, Statistical; Dyskinesia, Drug-Induced; Female; Levodopa; Male; MPTP Poisoning; Nicotine; Nicotinic Agonists; Parkinson Disease, Secondary; Saimiri	2013
Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 347, Issue:1 Topics: Animals; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Nicotinic; Saimiri	2013
Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice. Neuroscience, 2015, Jun-04, Volume: 295 Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Mice, Transgenic; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Protein Binding; Receptors, Nicotinic	2015
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias. Neurobiology of disease, 2016, Volume: 91 Topics: Animals; Choline O-Acetyltransferase; Corpus Striatum; Dyskinesia, Drug-Induced; Interneurons; Levodopa; Mice; Neostriatum; Nicotine; Nicotinic Agonists; Optogenetics	2016
Nicotine-induced acute hyperactivity is mediated by dopaminergic system in a sexually dimorphic manner. Neuroscience, 2016, 09-22, Volume: 332 Topics: Animals; Animals, Genetically Modified; Brain; Cholinergic Neurons; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drosophila; Drosophila Proteins; Dyskinesia, Drug-Induced; Female; Gene Knockdown Techniques; Male; Motor Activity; Nicotine; Nicotinic Agonists; Receptors, Dopamine; Receptors, Nicotinic; Sex Characteristics	2016
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:1 Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Infusion Pumps; Levodopa; Male; Nicotine; Parkinson Disease; Rats; Rats, Sprague-Dawley	2008
Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3 Topics: Amphetamine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Central Nervous System Stimulants; Cocaine; Conotoxins; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Male; Mecamylamine; Neostriatum; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereotyped Behavior	2010
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 338, Issue:3 Topics: Animals; Antiparkinson Agents; Autoradiography; Bridged Bicyclo Compounds, Heterocyclic; Corpus Striatum; Cotinine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Oxidopamine; Pyridines; Receptors, Nicotinic; Substantia Nigra; Sympatholytics	2011
Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter. Pharmacology, biochemistry, and behavior, 2012, Volume: 100, Issue:3 Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Generalization, Response; Imipramine; Male; Morpholines; Nicotine; Nicotinic Agonists; Norepinephrine Plasma Membrane Transport Proteins; Random Allocation; Rats; Rats, Sprague-Dawley; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tobacco Use Disorder	2012
Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 340, Issue:3 Topics: Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Haloperidol; Male; Movement Disorders; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic	2012
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice. Neuropharmacology, 2012, Volume: 63, Issue:3 Topics: Animals; Antiparkinson Agents; Autoradiography; Benserazide; Cotinine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Hydroxydopamines; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Receptors, Nicotinic	2012
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function. Neurobiology of disease, 2013, Volume: 50 Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Male; MPTP Poisoning; Nicotine; Nicotinic Agonists; Presynaptic Terminals; Receptors, Nicotinic; Saimiri	2013
The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release. Journal of neurochemistry, 2013, Volume: 125, Issue:2 Topics: Animals; Antiparkinson Agents; Autoradiography; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Male; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic	2013
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Annals of neurology, 2007, Volume: 62, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Circadian Rhythm; Dyskinesia, Drug-Induced; Levodopa; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Saimiri; Substantia Nigra; Time Factors	2007
Where there's smoke ... nicotine and psychiatric disorders. Biological psychiatry, 1991, Jul-15, Volume: 30, Issue:2 Topics: Depressive Disorder; Dyskinesia, Drug-Induced; Humans; Nicotine; Risk Factors; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders	1991
Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density. Biochemical and biophysical research communications, 1989, Feb-28, Volume: 159, Issue:1 Topics: Animals; Body Weight; Corpus Striatum; Dyskinesia, Drug-Induced; Eating; Haloperidol; Male; Nicotine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2	1989
Nicotine exposure and tardive dyskinesia. Biological psychiatry, 1987, Volume: 22, Issue:1 Topics: Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Schizophrenia; Smoking	1987